Table of Contents
Epidemiology of Idiopathic Pulmonary Fibrosis, David B. Coultas and Richard Hubbard; Genetics of Idiopathic Pulmonary Fibrosis and Other Variants, David A. Schwartz, Ganesh Raghu, and Momen M. Wahidi; Clinical Features and Differential Diagnosis of Idiopathic Pulmonary Fibrosis (IPF), Talmadge E. King, Jr and David Morris; Pathology of Usual Interstitial Pneumonia (UIP), William D. Travis; Non-Specific Interstitial Pneumonia Fernando Martinez, William Travis and Joseph P. Lynch; Physiology of Idiopathic Interstitial Pneumonia (Pulmonary Function and Exercise Testing), Fernando Martinez, Kevin Flaherty, Vibha Lama and Joseph P. Lynch; Radiology of Idiopathic Interstitial Fibrosis (Chest Radiographs, HRCT), David Zisman, Kevin Flaherty, Ella Kazerooni, Joseph P. Lynch and Fernando Martinez; Other Imaging Techniques for Idiopathic Interstitial Pneumonias (Radionuclide Studies, PET Scans), R.M. du Bois and Suveer Singho Bronchoalveolar; Lavage - Role in Diagnosis or Staging of Idiopathic Interstitial Fibrosis, Robert P. Baughman and Ulrich Costabel; Pulmonary Fibrosis Complicating Connective Tissue Disease, Athol Wells; Cytokine Phenotypes and the Progression of Chronic Pulmonary Fibrosis, Steven L. Kunkel; CXC Chemokines and Angiogenic Factors in the Pathogenesis of Pulmonary Fibrosis, Robert Strieter, John Belperio, and Michael Keane; Role of Polymorphonuclear Leukocytes in the Pathogenesis of Pulmonary Fibrosis, Eric White and Theodore Standiford; Integrins in Pulmonary Fibrosis, Dean Sheppard and Laura Koth; Oxidants and Antioxidants in IPF, Jurgen Behr; Fibrin Turnover in Pulmonary Fibrosis, Steven Idell; Arachidonic Acid Metabolite: Potential Mediators and Therapeutic Targets in Fibrotic Lung Disease, Marc Peters-Golden; Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Pulmonary Fibrosis, Moses Selman and Annie Pardo; Extracellular Matrix, Ronald Goldstein, David C. Rishikof and Dennis A. Ricupero; Role of Fibroblast and Myofibroblast in IPF, Sem Phan and Mehrnaz Gharaee-Kermani; Fibroblast Growth Factors (FGF), Peter Bitterman and Hyun Kim; Role of Type II Alveolar Epithelial Cells, Robert J. Mason and Josh Portnoy; Surfactant Apoproteins in the Pathogenesis of Pulmonary Fibrosis, Hiroki Takahashi; Bronchiolar Epitherlium in IPF/UIP, Marco Chilosi and Gianpietro Semenzato; Role of Viruses in the Pathogenesis of Pulmonary Fibrosis, Gary Hunninghake and Lois Geist; Current Treatment Options (Medical Therapy, Lung Transplantation), R.M. du Bois and G.P. Westall; Future Directions in Therapy, Marvin Schwarz; Future Directions in Genetic Strategies for Understanding and Treating Pulmonary Fibrosis, Ronald G. Crystal.
